Neuroprotection for acute ischaemic stroke: Hope reignited

Lancet Neurology

Volumn 5, Issue 4, 2006, Pages 287-288

  Hankey, Graeme J ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; DISUFENTON SODIUM;

ARTICLE; CEREBROVASCULAR ACCIDENT; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPOKALEMIA; NEUROPROTECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL; TREATMENT OUTCOME;

EID: 33644984576     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(06)70387-8     Document Type: Letter

References (7)

1. JM Wardlaw, G del Zoppo, T Yamaguchi, E Berge Thrombolysis for acute ischaemic stroke Cochrane Database Syst Rev 3 2003 CD000213
2. GJ Hankey Stroke treatment and prevention: an evidence-based approach 2005 Cambridge University Press
3. A Dávalos, J Castillo, J Álavarez-Sabin Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials Stroke 33 2002 2850 2857
4. DJ Gladstone, SE Black, AM Hakim for the Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery Toward wisdom from failure: lesson from neuroprotective stroke trials and new therapeutic directions Stroke 33 2002 2123 2136
5. M Fisher, PA Cyrus, SM Davis Recommendations for advancing development of acute stroke therapies: stroke therapy academic industry roundtable 3 Stroke 34 2003 1539 1546
6. KR Lees, JA Zivin, T Ashwood for the Stroke-Acute Ischemic-NXY Treatment (SAINT I) trial investigators: NXY-059 for acute ischaemic stroke N Engl J Med 354 2006 588 600
7. GA Donnan, SM Davis, M Kaste for the International Trial Subcommittee of the International Stroke Liaison Committee, American Stroke Association Recommendations for the relationship between sponsors and investigators in the design and conduct of clinical stroke trials Stroke 34 2003 1041 1045